Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#2 Fake World Assets Fake World Assets +18.28%
#3 Status Status +17.90%
#4 GoPlus Security GoPlus Security +11.51%
#5 Ontology Gas Ontology Gas +10.01%
#6 Bedrock Bedrock +7.70%
#7 DMT-NAT DMT-NAT +7.61%
#8 Cap Cap +6.73%
#9 Provenance Blockchain Provenance Blockchain +6.73%
#10 Janction Janction +5.45%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Khiron Life Sciences Corp. Khiron Life Sciences Corp.

Khiron Life Sciences Corp.

KHRN
Rangering i aksjer #34032
Khiron Life Sciences Corp. is an integrated enterprise focusing on medical and... Khiron Life Sciences Corp. is an integrated enterprise focusing on medical and cannabis solutions across Latin America and Europe. Its operations are structured into Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company's primary activities include the cultivation, production, distribution, and international export of medical cannabis, encompassing both tetrahydrocannabinol (THC) and cannabidiol (CBD). Complementing this, Khiron manages a network of health centers and satellite clinics, operating under the ILANS and Zerenia brands, with specific Zerenia clinics established in Medellin and Peru. Furthermore, it develops CBD-infused cosmeceutical products marketed under the Kuida brand. Khiron Life Sciences Corp. was founded in 2012 and maintains its headquarters in Vancouver, Canada.
Aksjekurs
$0.02971559
Sist synkronisert: 2023-05-17
Markedsverdi
$6.37M
Endring (1 dag)
0.13%
Endring (1 år)
0.00%
Land
CA
Handel Khiron Life Sciences Corp. (KHRN)

Kategori

Healthcare
Inntekter for Khiron Life Sciences Corp. (KHRN)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Khiron Life Sciences Corp. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Khiron Life Sciences Corp. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN